Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities by Charlotte Lemech, Hendrik-Tobias Arkenau

Get full text

Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities by Charlotte Lemech, Hendrik-Tobias Arkenau

Get full text

Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice by Hendrik-Tobias Arkenau, Charlotte Lemech

Get full text

The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence by Charlotte Lemech, Jeffrey Infante, Hendrik-Tobias Arkenau

Get full text

Research biopsies in the context of early phase oncology studies: clinical and ethical considerations by Matilde Saggese, Divyanshu Dua, Emily Simmons, Charlotte Lemech, Hendrik-Tobias Arkenau

Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors by Nick Perry, Sue Moss, Steve Dixon, Sue Milner, Kefah Mokbel, Charlotte Lemech, Hendrik-Tobias Arkenau, Stephen Duffy, Katja Pinker

Get full text

427 Efficacy and safety of AK112, an anti-PD-1/VEGF-A bispecific antibody, in patients with platinum-resistant/refractory epithelial ovarian cancer in a Phase 1 study by Yu Xia, Charlotte Lemech, Xiaoping Jin, Jermaine Coward, Anna Mislang, Baiyong Li, Kon Yew Kwek, Yiting Zhou, Max Wang

Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind,... by Christopher John Wynne, Alexandra Cole, Charlotte Lemech, Guoqin Wang, Yu Zhang, Benchao Chen, Max Wang, Baiyong Li, Michelle Xia, Rodney Sinclair

Get full text

Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors by Wenjing Wang, Yu Xia, Charlotte Lemech, Adnan Nagrial, Baiyong Li, Zhongmin Maxwell Wang, Sophia Frentzas, Anna Rachelle Austria Mislang, Craig Underhill, Jermaine I G Coward

Get full text

340 A phase Ib study of the safety and tolerability of pixatimod plus nivolumab in subjects with advanced solid tumors with an expansion cohort in metastatic pancreatic adenocarcin... by Matthew Burge, David Goldstein, Andrew Haydon, Nick Pavlakis, Michael Brown, Charlotte Lemech, Edward Hammond, Darryn Bampton, Keith Dredge, Amanda Stanley, Lucie Leveque-ElMouttie, Grace Chojnowski

Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metast... by Matthew Burge, David Goldstein, Andrew Haydon, Nick Pavlakis, Charlotte Lemech, Edward Hammond, Darryn Bampton, Keith Dredge, Michael P Brown, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski

Get full text

760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors by Kim Margolin, Victoria Atkinson, Charlotte Lemech, Philippe Bedard, Przemyslaw Twardowski, Sajeve Thomas, Amy Prawira, Arash Yavari, Peter Lloyd, Warren Brenner, Rosemina Merchant, Carole Galligan, Fahar Merchant, Minh D To, Melissa Coello, Jesus Fuentes Antras, Sudhir Madduri Karanam, Matthen Mathew

P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEU... by Matko Kalac, Mark Hertzberg, Chan Cheah, Vincent Ribrag, Pablo Abrisquet Acosta, Stephen Opat, Emmanuel Bachy, Loïc Ysebaert, Lihua Qiu, Shuhua Yi, Noriko Nishimura, Charlotte Lemech, Jacqueline Bussolari, Changchun Deng, Tianbao Lu, Liang Xiu, Sandy Van Hemelryck, Ulrike Philippar, Yue Guo, Virginie Soete, Isabel Soriano, Nele Fourneau, John Gerecitano, Franck Morschhauser

Get full text

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) by Sneha Berry, Nicolas Giraldo, Peter Nguyen, Benjamin Green, Haiying Xu, Aleksandra Ogurtsova, Abha Soni, Farah Succaria, Daphne Wang, Charles Roberts, Julie Stein, Elizabeth Engle, Drew Pardoll, Robert Anders, Tricia Cottrell, Janis M. Taube, Ben Tran, Mark Voskoboynik, James Kuo, Yung-Lue Bang, Hyun-Cheo Chung, Myung-Ju Ahn, Sang-We Kim, Ayesh Perera, Daniel Freeman, Ikbel Achour, Raffaella Faggioni, Feng Xiao, Charles Ferte, Charlotte Lemech, Funda Meric-Bernstam, Theresa Werner, Stephen Hodi, Wells Messersmith, Nancy Lewis, Craig Talluto, Mirek Dostalek, Aiyang Tao, Sarah McWhirter, Damian Trujillo, Jason Luke, Chunxiao Xu, BoMarelli, Jin Qi, Guozhong Qin, Huakui Yu, Molly Jenkins, Kin-Ming Lo, Joern-Peter Halle, Yan Lan, Matthew Taylor, Nicholas Vogelzang, Allen Cohn, Daniel Stepan, Robert Shumaker, Corina Dutcus, Matthew Guo, Emmett Schmidt, Drew Rasco, Marcia Brose, Nicholas Vogelzang, Christopher Di Simone, Sharad Jain, Donald Richards, Carlos Encarnacion, Drew Rasco, Robert Shumaker, Corina Dutcus, Daniel Stepan, Matthew Guo, Emmett Schmidt, Matthew Taylor, Nicholas Vogelzang, Carlos Encarnacion, Allen Cohn, Christopher Di Simone, Drew Rasco, Donald Richards, Matthew Taylor, Corina Dutcus, Daniel Stepan, Robert Shumaker, Matthew Guo, Emmett Schmidt, James Mier, Jeongshin An, Yeun-yeoul Yang, Won-Hee Lee, Jinho Yang, Jong-kyu Kim, Hyun Goo Kim, Se Hyun Paek, Jun Woo Lee, Joohyun Woo, Jong Bin Kim, Hyungju Kwon, Woosung Lim, Nam Sun Paik, Yoon-Keun Kim, Byung-In Moon, Filip Janku, David Tan, Juan Martin-Liberal, Shunji Takahashi, Ravit Geva, Ayca Gucalp, Xueying Chen, Kulandayan Subramanian, Jennifer Mataraza, Jennifer Wheler, Philippe Bedard

Get full text